Double uterus-hemivagina-renal agenesis syndrome (DUHRA) is a rare congenital disorder characterized by the absence of one kidney, a partial or complete absence of one of the two uterine horns, and a partial or complete absence of one of the two vaginas. It is a form of Mullerian agenesis, a condition in which the female reproductive organs do not develop normally. Symptoms of DUHRA may include abdominal pain, irregular menstrual periods, infertility, and urinary tract infections. Treatment typically involves hormone therapy and surgery to correct the reproductive organs.

The symptoms of Double uterus-hemivagina-renal agenesis syndrome vary from person to person, but may include:

- Abnormal development of the reproductive organs, including a double uterus, a single cervix, and a single vagina
- Abnormal development of the urinary tract, including a single kidney, a single ureter, and a single bladder
- Abnormal development of the reproductive organs, including a single fallopian tube and a single ovary
- Abnormal development of the reproductive organs, including a single testis and a single epididymis
- Abnormal development of the reproductive organs, including a single uterus and a single vagina
- Abnormal development of the reproductive organs, including a single cervix and a single uterus
- Abnormal development of the reproductive organs, including a single uterus and a single

Double uterus-hemivagina-renal agenesis syndrome is a rare congenital disorder caused by a genetic mutation. The exact cause of the mutation is unknown, but it is believed to be caused by a combination of environmental and genetic factors. It is thought that the mutation occurs during the early stages of embryonic development, resulting in the abnormal development of the reproductive organs, urinary tract, and kidneys.

Unfortunately, there is no cure for Double Uterus-Hemivagina-Renal Agenesis Syndrome. Treatment is focused on managing the symptoms and complications associated with the condition. This may include:

• Surgery to correct any structural abnormalities in the reproductive organs

• Hormone replacement therapy to help regulate menstrual cycles

• Antibiotics to treat any infections

• Pain medications to help manage any pain associated with the condition

• Regular monitoring of kidney function

• Regular gynecological exams to monitor for any changes in the reproductive organs

• Genetic counseling to help families understand the condition and its implications for future pregnancies.

1. Genetic mutation: Double uterus-hemivagina-renal agenesis syndrome is caused by a genetic mutation in the HOXA13 gene.

2. Family history: Having a family history of the condition increases the risk of developing the syndrome.

3. Gender: Females are more likely to be affected by the syndrome than males.

4. Age: The syndrome is more common in infants and young children.

Unfortunately, there is no cure for Double Uterus-Hemivagina-Renal Agenesis Syndrome. However, there are medications that can help manage the symptoms associated with the condition. These medications may include hormone replacement therapy, pain medications, and antibiotics. Additionally, surgery may be recommended to correct any anatomical abnormalities associated with the condition.